BMS granted FDA approval for immunotherapy combination in colorectal cancer - PMLiVE More than 154,000 cases of the disease are expected to be diagnosed in the US this year

#FDAapproval #immunotherapy #colorectalcancer #BristolMyersSquibb #Opdivo #Yervoy #OpdivoplusYervoy #nivolumabplusipilimumab #MSIHcolorectalcancer #dMMRcolorectalcancer #dMMRtumours #MSIHtumours #FDAacceleratedapprovalspathway #CheckMate8HWtrial
pmlive.com/pharma_news/...